Supriya Life - Pullback Trade
Good numbers by the company and expansion to 2x capacity complete. Just awaiting US FDA approval now.
The company has a good growth trajectory going ahead...modestly valued at 30 PE when you compare it to other pharma names most of which are trading at over 50PE..
There could be some rerating here too..
If it pulls back to 570 I think its a buy with Stoploss below 520.
The company has a good growth trajectory going ahead...modestly valued at 30 PE when you compare it to other pharma names most of which are trading at over 50PE..
There could be some rerating here too..
If it pulls back to 570 I think its a buy with Stoploss below 520.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.